FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3209326437> ?p ?o ?g. }

• W3209326437 endingPage "2359" @default.
• W3209326437 startingPage "2359" @default.
• W3209326437 abstract "Ann Oncol 2014; 25: 2351–2356 (doi: 10.1093/annonc/mdu465)In the original manuscript, there was an error in the formatting of Table 2.Table 2Adverse events considered by the investigator to be related to treatment, except alopecia (N = 19)aAdverse events considered not related to treatment were: grade 3 asthenia and grade 3 hyperglycaemia in 1 patient; grade 2 AEs in 13 patients [asthenia (n = 4), pain (n = 4), infection (n = 4), headache (n = 3), balance disorder (n = 3), constipation (n = 2), insomnia (n = 2), anorexia (n = 1), hyperglycaemia (n = 1), hyponatremia (n = 1), paraesthesia (n = 1), cutaneous/mucus disorder (n = 1), liver disorder (n = 1), ocular disorder (n = 1), epigastralgia (n = 1)].No. of patientsDose level 0 (N = 3)Dose level 1 (N = 4)Dose level 2 (N = 3)Dose level 3 (N = 9)Total no. of patientsGrade 1Grade 2Grade 1Grade 2Grade 1Grade 2Grade 1Grade 2In-field side-effects Headache11 Nausea1214 Vomiting112No. of patients11035Out-field side-effects Arterial hypertension134 Asthenia1113 Pain11 Abdominal pain11 Lymphopenia11 Skin/mucus disorders11 Appetite loss11No. of patients11169Total no. of patients111811a Adverse events considered not related to treatment were: grade 3 asthenia and grade 3 hyperglycaemia in 1 patient; grade 2 AEs in 13 patients [asthenia (n = 4), pain (n = 4), infection (n = 4), headache (n = 3), balance disorder (n = 3), constipation (n = 2), insomnia (n = 2), anorexia (n = 1), hyperglycaemia (n = 1), hyponatremia (n = 1), paraesthesia (n = 1), cutaneous/mucus disorder (n = 1), liver disorder (n = 1), ocular disorder (n = 1), epigastralgia (n = 1)]. Open table in a new tab The corrected table is below. Ann Oncol 2014; 25: 2351–2356 (doi: 10.1093/annonc/mdu465) In the original manuscript, there was an error in the formatting of Table 2. The corrected table is below. REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumoursAnnals of OncologyVol. 25Issue 12PreviewBrain metastases (BMs) are associated with a poor prognosis. Standard treatment comprises whole-brain radiation therapy (WBRT). As neo-angiogenesis is crucial in BM growth, combining angiogenesis inhibitors such as bevacizumab with radiotherapy is of interest. We aimed to identify the optimal regimen of bevacizumab combined with WBRT for BM for phase II evaluation and provide preliminary efficacy data. Full-Text PDF Open Archive" @default.
• W3209326437 created "2021-11-08" @default.
• W3209326437 creator A5003718994 @default.
• W3209326437 creator A5010923467 @default.
• W3209326437 creator A5012593402 @default.
• W3209326437 creator A5015165342 @default.
• W3209326437 creator A5021172260 @default.
• W3209326437 creator A5028829159 @default.
• W3209326437 creator A5031144079 @default.
• W3209326437 creator A5038830638 @default.
• W3209326437 creator A5039116194 @default.
• W3209326437 creator A5042347658 @default.
• W3209326437 creator A5046156275 @default.
• W3209326437 creator A5047514488 @default.
• W3209326437 creator A5048144414 @default.
• W3209326437 creator A5048289264 @default.
• W3209326437 creator A5051042353 @default.
• W3209326437 creator A5055495127 @default.
• W3209326437 creator A5066201418 @default.
• W3209326437 creator A5071553983 @default.
• W3209326437 creator A5079006574 @default.
• W3209326437 creator A5082498887 @default.
• W3209326437 creator A5083205588 @default.
• W3209326437 creator A5089570643 @default.
• W3209326437 creator A5090177087 @default.
• W3209326437 creator A5090436898 @default.
• W3209326437 date "2015-11-01" @default.
• W3209326437 modified "2023-09-28" @default.
• W3209326437 title "Corrections to “REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours”" @default.
• W3209326437 doi "https://doi.org/10.1093/annonc/mdv386" @default.
• W3209326437 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26504187" @default.
• W3209326437 hasPublicationYear "2015" @default.
• W3209326437 type Work @default.
• W3209326437 sameAs 3209326437 @default.
• W3209326437 citedByCount "1" @default.
• W3209326437 countsByYear W32093264372018 @default.
• W3209326437 crossrefType "journal-article" @default.
• W3209326437 hasAuthorship W3209326437A5003718994 @default.
• W3209326437 hasAuthorship W3209326437A5010923467 @default.
• W3209326437 hasAuthorship W3209326437A5012593402 @default.
• W3209326437 hasAuthorship W3209326437A5015165342 @default.
• W3209326437 hasAuthorship W3209326437A5021172260 @default.
• W3209326437 hasAuthorship W3209326437A5028829159 @default.
• W3209326437 hasAuthorship W3209326437A5031144079 @default.
• W3209326437 hasAuthorship W3209326437A5038830638 @default.
• W3209326437 hasAuthorship W3209326437A5039116194 @default.
• W3209326437 hasAuthorship W3209326437A5042347658 @default.
• W3209326437 hasAuthorship W3209326437A5046156275 @default.
• W3209326437 hasAuthorship W3209326437A5047514488 @default.
• W3209326437 hasAuthorship W3209326437A5048144414 @default.
• W3209326437 hasAuthorship W3209326437A5048289264 @default.
• W3209326437 hasAuthorship W3209326437A5051042353 @default.
• W3209326437 hasAuthorship W3209326437A5055495127 @default.
• W3209326437 hasAuthorship W3209326437A5066201418 @default.
• W3209326437 hasAuthorship W3209326437A5071553983 @default.
• W3209326437 hasAuthorship W3209326437A5079006574 @default.
• W3209326437 hasAuthorship W3209326437A5082498887 @default.
• W3209326437 hasAuthorship W3209326437A5083205588 @default.
• W3209326437 hasAuthorship W3209326437A5089570643 @default.
• W3209326437 hasAuthorship W3209326437A5090177087 @default.
• W3209326437 hasAuthorship W3209326437A5090436898 @default.
• W3209326437 hasBestOaLocation W32093264371 @default.
• W3209326437 hasConcept C126322002 @default.
• W3209326437 hasConcept C197934379 @default.
• W3209326437 hasConcept C2776703092 @default.
• W3209326437 hasConcept C2778654693 @default.
• W3209326437 hasConcept C2780580376 @default.
• W3209326437 hasConcept C2780955771 @default.
• W3209326437 hasConcept C2781112942 @default.
• W3209326437 hasConcept C71924100 @default.
• W3209326437 hasConcept C90924648 @default.
• W3209326437 hasConceptScore W3209326437C126322002 @default.
• W3209326437 hasConceptScore W3209326437C197934379 @default.
• W3209326437 hasConceptScore W3209326437C2776703092 @default.
• W3209326437 hasConceptScore W3209326437C2778654693 @default.
• W3209326437 hasConceptScore W3209326437C2780580376 @default.
• W3209326437 hasConceptScore W3209326437C2780955771 @default.
• W3209326437 hasConceptScore W3209326437C2781112942 @default.
• W3209326437 hasConceptScore W3209326437C71924100 @default.
• W3209326437 hasConceptScore W3209326437C90924648 @default.
• W3209326437 hasIssue "11" @default.
• W3209326437 hasLocation W32093264371 @default.
• W3209326437 hasLocation W32093264372 @default.
• W3209326437 hasLocation W32093264373 @default.
• W3209326437 hasLocation W32093264374 @default.
• W3209326437 hasOpenAccess W3209326437 @default.
• W3209326437 hasPrimaryLocation W32093264371 @default.
• W3209326437 hasRelatedWork W2376132146 @default.
• W3209326437 hasRelatedWork W2403278642 @default.
• W3209326437 hasRelatedWork W2411848747 @default.
• W3209326437 hasRelatedWork W2461411390 @default.
• W3209326437 hasRelatedWork W2470162756 @default.
• W3209326437 hasRelatedWork W2483324221 @default.
• W3209326437 hasRelatedWork W3032341092 @default.
• W3209326437 hasRelatedWork W4286267926 @default.
• W3209326437 hasRelatedWork W4301107981 @default.
• W3209326437 hasRelatedWork W4309110366 @default.
• W3209326437 hasVolume "26" @default.

• next